{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:26:06Z","timestamp":1771010766841,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ando.2009.12.001","type":"journal-article","created":{"date-parts":[[2010,1,25]],"date-time":"2010-01-25T02:04:41Z","timestamp":1264385081000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Anti-androgen Treatments"],"prefix":"10.1016","volume":"71","author":[{"given":"Anne","family":"Bachelot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Salenave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Kerlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-B\u00e9atrice","family":"Galand-Portier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2009.12.001_bib1","doi-asserted-by":"crossref","unstructured":"RotterdamESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19:41-7.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.ando.2009.12.001_bib2","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Farquhar","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2009.12.001_bib3","first-page":"CD004684","article-title":"Laser and photoepilation for unwanted hair growth","author":"Haedersdal","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2009.12.001_bib4","first-page":"CD001125","article-title":"Cyproterone acetate for hirsutism","author":"Van der Spuy","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2009.12.001_bib5","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2009.12.001_bib6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Anti-androgens for the treatment of hirsutism: A systematic review and meta-analyses of randomized controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: An endocrine society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/jcem-63-4-1031","article-title":"Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease","volume":"63","author":"Couzinet","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-961807","article-title":"Sexual hormones in human skin","volume":"39","author":"Zouboulis","year":"2007","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2009.12.001_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.maturitas.2008.11.011","article-title":"Pharmacological profile of progestins","volume":"61","author":"Sitruk-Ware","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.ando.2009.12.001_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2003.10.005","article-title":"Third-generation oral contraceptive use and cardiovascular risk factors","volume":"172","author":"D\u00f6ring","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ando.2009.12.001_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2009.12.001_bib13","first-page":"CD006133","article-title":"Steroidal contraceptives: Effect on carbohydrate metabolism in women without diabetes mellitus","author":"Lopez","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2009.12.001_bib14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","article-title":"Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: Oral contraceptives and the risk of ischemic stroke","volume":"33","author":"Kemmeren","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ando.2009.12.001_bib15","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2009.12.001_bib16","first-page":"109","article-title":"Treatment of hirsutism in polycystic ovarian syndrome with Diane, 50mcg ethinyl estradiol and 2mg cyproterone acetate","volume":"9","author":"Saeed","year":"1993","journal-title":"Specialist"},{"key":"10.1016\/j.ando.2009.12.001_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0015-0282(16)54291-5","article-title":"Long-term treatment of hirsutism: Desogestrel compared with cyproterone acetate in oral contraceptives","volume":"55","author":"Porcile","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2009.12.001_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/09513590801948309","volume":"24","author":"Gregoriou","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ando.2009.12.001_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fertnstert.2005.07.1311","article-title":"Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism","volume":"85","author":"Batukan","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2009.12.001_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0010-7824(03)00027-1","article-title":"Efficacy of second versus third-generation oral contraceptives in the treatment of hirsutism","volume":"67","author":"Breitkopf","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2009.12.001_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2009.12.001_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.2000.tb06236.x","article-title":"Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile","volume":"900","author":"Creatsas","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ando.2009.12.001_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2005.07.010","article-title":"Treating acne with oral contraceptives: Use of lower doses","volume":"73","author":"Huber","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2009.12.001_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2265.2007.03105.x","article-title":"A systematic review of commonly used medical treatments for hirsutism in women","volume":"68","author":"Koulouri","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2009.12.001_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/09513599609012316","article-title":"Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome","volume":"10","author":"G\u00f6kmen","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ando.2009.12.001_bib26","first-page":"89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: A randomized, double-blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/pgmj.65.765.459","article-title":"Lack of effect of spironolactone on hair shaft diameter in hirsute females","volume":"65","author":"McLellan","year":"1989","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ando.2009.12.001_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0015-0282(16)48972-7","article-title":"The effects of spironolactone on adrenal steroidogenesis in hirsute women","volume":"44","author":"Serafini","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2009.12.001_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJM200202073460619","article-title":"Spironolactone and ACE inhibition in chronic renal failure","volume":"346","author":"Epstein","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2009.12.001_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","article-title":"Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome","volume":"60","author":"Gambineri","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2009.12.001_bib31","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/humrep\/dei004","article-title":"Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women","volume":"20","author":"Ibanez","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2009.12.001_bib32","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1210\/jc.2006-2798","article-title":"Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: A 12-month, double-blind, parallel clinical trial","volume":"92","author":"Calaf","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib33","first-page":"995","article-title":"The evaluation and management of hirsutism","volume":"101","author":"Azziz","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ando.2009.12.001_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ando.2009.12.001_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0015-0282(16)57727-9","article-title":"Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism","volume":"64","author":"Ciotta","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2009.12.001_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/gye.17.1.57.63","article-title":"The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism","volume":"17","author":"Lakryc","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ando.2009.12.001_bib37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350769","article-title":"Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism","volume":"21","author":"Sahin","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2009.12.001_bib38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0015-0282(00)01764-7","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism","volume":"75","author":"Sahin","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2009.12.001_bib39","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0015-0282(99)00633-0","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism","volume":"73","author":"Tartagni","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2009.12.001_bib40","first-page":"3412","article-title":"Comparison of a gonadotropin-releasing hormone agonist and a low-dose oral contraceptive given alone or together in the treatment of hirsutism","volume":"80","author":"Heiner","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib41","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1210\/jcem-70-4-1096","article-title":"Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: The relative importance of the ovary and the adrenal in the pathogenesis of hirsutism","volume":"70","author":"Rittmaster","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib42","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1210\/jcem-63-4-854","article-title":"Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin)","volume":"63","author":"Andreyko","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib43","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/jcem-56-5-897","article-title":"Judd HL.Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist","volume":"56","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/jcem-65-4-773","article-title":"Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease","volume":"65","author":"Steingold","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib45","first-page":"1169","article-title":"Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: A clinical research center study","volume":"80","author":"Carr","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0020-7292(93)90629-B","article-title":"Treatment of polycystic ovarian disease during adolescence with ethinyl estradiol\/cyproterone acetate versus a D-Tr-6-LHRH analog","volume":"42","author":"Creatsas","year":"1993","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ando.2009.12.001_bib47","first-page":"3406","article-title":"Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: A prospective randomized study","volume":"80","author":"Azziz","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.12.001_bib48","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/humrep\/12.4.663","article-title":"Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission","volume":"12","author":"Carmina","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2009.12.001_bib49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/14764170310001438","article-title":"Hair reduction: 48 months of experience with 800nm diode laser","volume":"5","author":"Kopera","year":"2003","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.ando.2009.12.001_bib50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00128071-200102030-00009","article-title":"Topical eflornithine","volume":"2","author":"Balfour","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ando.2009.12.001_bib51","first-page":"1237","article-title":"Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: A randomized trial","volume":"32","author":"Smith","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ando.2009.12.001_bib52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2006.09.025","article-title":"A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women","volume":"57","author":"Hamzavi","year":"2007","journal-title":"J Am Acad Dermatol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426609003102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426609003102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:43:41Z","timestamp":1757717021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426609003102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0003426609003102"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2009.12.001","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-androgen Treatments","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2009.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2009.12.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}